Research Progress of Genomics Applications in Secondary Metabolites of Medicinal Plants: A Case Study in Safflower
Zhihua Wu,
No information about this author
Yan Na Hu,
No information about this author
Rui Hao
No information about this author
et al.
International Journal of Molecular Sciences,
Journal Year:
2025,
Volume and Issue:
26(8), P. 3867 - 3867
Published: April 19, 2025
Medicinal
plants,
recognized
as
significant
natural
resources,
have
gained
prominence
in
response
to
the
increasing
global
demand
for
herbal
medicines,
necessitating
large-scale
production
of
these
plants
and
their
derivatives.
are
exposed
a
variety
internal
external
factors
that
interact
influence
biosynthesis
accumulation
secondary
metabolites.
With
rapid
development
omics
technologies
such
genomics,
transcriptomics,
proteomics,
metabolomics,
multi-omics
become
important
tools
revealing
complexity
functionality
organisms.
They
conducive
further
uncovering
biological
activities
metabolites
medicinal
clarifying
molecular
mechanisms
underlying
Also,
artificial
intelligence
(AI)
technology
accelerates
comprehensive
utilization
high-dimensional
datasets
offers
transformative
potential
analysis.
However,
there
is
currently
no
systematic
review
summarizing
genomic
metabolite
plants.
Safflower
(Carthamus
tinctorius
L.)
has
rich
diverse
bioactive
flavonoids,
among
which
Hydroxysafflor
yellow
A
(HSYA)
specific
safflower
emerging
medication
treating
wide
range
diseases.
Hence,
progress
been
made
study
an
excellent
example
regulation
recent
years.
Here,
we
on
understanding
main
at
level,
summarize
various
types
contents,
with
particular
focus
flavonoids.
This
aims
provide
insight
into
regulatory
from
perspective
genomics.
Language: Английский
Widely targeted metabolomic, transcriptomic and network pharmacology approach reveals the differences in non-volatile and volatile metabolites and health-promoting functions in the three durian fruits
Heng Liang,
No information about this author
Lijun Guo,
No information about this author
Xiuxiu Sun
No information about this author
et al.
Journal of Future Foods,
Journal Year:
2025,
Volume and Issue:
unknown
Published: May 1, 2025
Language: Английский
Metabolomics and transcriptomics indicate the changes in medicinal components of Amygdalus mongolica kernels during different developmental stages
Frontiers in Plant Science,
Journal Year:
2025,
Volume and Issue:
16
Published: May 23, 2025
Amygdalus
mongolica
is
a
traditional
Chinese
and
Mongolian
medicine
quite
effective
in
relieving
cough
eliminating
phlegm.
In
this
study,
ultra-high
performance
liquid
chromatography-mass
spectrometry
(UPLC-MS)
was
used
to
perform
metabolomics
analysis,
combined
with
transcriptomic
sequencing,
study
the
samples
of
A.
at
early,
middle
late
growth
stages.
A
comprehensive
analysis
conducted
systematically
investigate
dynamic
changes
developmental
trajectories
kernel
progression
across
distinct
stages,
utilizing
differential
expression
pathway
enrichment
approaches.
total
104
significant
metabolites
were
identified
different
stages:
early
stage
(E),
(M),
(L).
Specifically,
68
36
detected
comparisons
E
vs.
M
L,
respectively.
Among
them,
29
21
exhibiting
up-regulation.
comparison,
39
15
demonstrated
down-regulation.
Transcriptomic
133
differentially
expressed
genes
associated
62
pathways
M.
Simultaneously,
14
linked
13
L.
The
accumulation
various
varied
marked
increase
amino
acids
during
phases,
alongside
fluctuations
levels
flavonoid
compounds.
conclusion,
reveals
variations
content
types
acid
compounds
key
within
relevant
kernels
throughout
Especially,
compound
advancing
stages
highlights
their
substantial
medicinal
potential.
These
findings
provide
foundation
for
future
developing
valuable
ingredients
kernels.
Language: Английский